NCT07129772 2025-09-04
Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma
The University of Hong Kong
Phase 2 Not yet recruiting
Clinical Trials
6 trialsNCT07138989 2025-08-24
EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT06364826 2024-04-15
Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 2 Not yet recruiting
NCT06331845 2024-03-26
Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT05898256 2023-06-12
Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma
Guangxi Medical University
Phase 1/2 Not yet recruiting
NCT04890522 2021-05-18
An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC
Sun Yat-sen University
Phase 2/3 Not yet recruiting